C
Curaway Medical Technology
Medical devices for interventional oncology and surgery.
About Curaway Medical Technology
Founded in June 2014, Zhejiang Curaway Medical Technology Co., Ltd. is a manufacturer and trading company specializing in medical devices for minimally invasive procedures. The firm operates from Hangzhou, China, and has expanded its reach to over 40 countries, including markets in North America, Europe, and Asia. Curaway has achieved significant milestones, including being recognized as a "National High- and New-Technology Enterprise" in China and securing Series A, B, and C venture capital funding, with the most recent round in April 2024. Its products have obtained NMPA, CE, and U.S. FDA certifications. Curaway's business is centered on the research, development, production, and sale of medical devices across four main areas: interventional oncology, peripheral vascular intervention, delicate surgery, and intelligent medical technology. The company serves healthcare providers with a business model focused on the direct sale of its devices. Its R&D department is structured into three divisions: consumables, equipment, and intelligent medical, enabling a focused approach to product development. This structure supports the company's goal of localizing the production of high-end medical devices within China. The product portfolio includes a range of devices for diagnosis and treatment. Key offerings include biopsy needles, radiofrequency ablation (RFA) systems, irreversible electroporation (IRE) systems, and microwave ablation systems. A notable product is a CT-guided surgical navigation puncture robot designed for precision in minimally invasive surgery. The company also produces a variety of surgical consumables such as disposable needle guiders, breast localization wires, wound closure devices, and wearable pressure bandages. Curaway's strategy is to provide solutions that result in minimal trauma, fewer complications, and faster recovery for patients.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | May 2026 | $28M | $110M | Haibang Capital · Hunan Xingxiang Investment Holding · Oriental Fortune Capital | ↗ |
Growth signals
Latest recorded traffic for Curaway Medical Technology is 2.2K monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Curaway Medical Technology in its local ecosystem
The Curaway Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- HCHaibang Capital
- HHHunan Xingxiang Investment Holding
Oriental Fortune Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Curaway Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Curaway Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






